Viridian Therapeutics
Price & Volume
Stats
See more52W Range | $13.18-$34.29 |
Market Cap | $1.9B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $70.9M |
Revenue Growth (YoY) | 95.8% |
Gross Profit (12 Mos) | -$268.7M |
Diluted EPS | -$3.35 |
News
See moreYahoo Finance • 6 days ago
Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M
Yahoo Finance • 7 days ago
Viridian Metals Expands Drill Program to 50 Holes at Kraken Copper-Nickel Project
Yahoo Finance • 9 days ago
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
Yahoo Finance • last month
Truist Reiterates Buy Rating for Viridian Therapeutics (VRDN)
About
CEO | Mr. Stephen F. Mahoney J.D., MBA |
Address | 221 Crescent Street, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 252 |